Understanding cell signalling mechanisms activated by relaxin family peptides: targets with therapeutic potential.

  • Summers, Roger (Primary Chief Investigator (PCI))
  • Bathgate, Ross, (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date2/01/07 → 31/12/08

Funding

  • National Health & Medical Research Council (NHMRC)
  • National Health & Medical Research Council (NHMRC): AUD447,000.00
View all
View less

Related content

Research Output

Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis

Research output: Contribution to journal › Article › Research › peer-review